Literature DB >> 8419351

Complex-dependent inhibition of factor VIIa by antithrombin III and heparin.

J H Lawson1, S Butenas, N Ribarik, K G Mann.   

Abstract

The regulation of the factor VIIa-tissue factor complex is essential for control of the hemostatic response. However, the role of the inhibitor antithrombin III in the regulation of factor VIIa has remained in question. The inhibition of factor VIIa activity by antithrombin III and heparin in the presence and absence of tissue factor was evaluated using the fluorescent substrate m-LGR-nds. Our data show that the activity of recombinant human factor VIIa is inhibited by antithrombin III in the presence of heparin at a rate of 1.7 x 10(2) M-1 s-1. In the presence of tissue factor, the rate constant for this reaction increases to 5.6 x 10(3) M-1 s-1. A 1:1 stoichiometric complex between factor VIIa and antithrombin III, with an apparent molecular weight of 110,000, was detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A heterogeneous mixture of factor VIIa products with molecular weights between 50,000 and 80,000, most likely representing proteolytically degraded factor VIIa-antithrombin III complexes, was also observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419351

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog.

Authors:  T Knudsen; A T Kristensen; T C Nichols; H Agersø; A L Jensen; M Kjalke; M Ezban; M Tranholm
Journal:  Haemophilia       Date:  2011-06-06       Impact factor: 4.287

2.  Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.

Authors:  Angela Silveira; Daniela Scanavini; Susanna Boquist; Carl-Göran Ericsson; Mai-Lis Hellénius; Karin Leander; Ulf de Faire; John Ohrvik; Barry Woodhams; James H Morrissey; Anders Hamsten
Journal:  Thromb Res       Date:  2011-09-16       Impact factor: 3.944

3.  Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.

Authors:  L Yang; C Manithody; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

4.  Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients.

Authors:  H Agersø; D F Brophy; H Pelzer; E J Martin; M Carr; U Hedner; M Ezban
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

5.  Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin.

Authors:  Lars C Petersen; Ditte M Karpf; Henrik Agersø; Mette B Hermit; Hermann Pelzer; Egon Persson; Timothy C Nichols; Mirella Ezban
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

6.  Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.

Authors:  P Sen; A A Komissarov; G Florova; S Idell; U R Pendurthi; L Vijaya Mohan Rao
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

Review 7.  How it all starts: Initiation of the clotting cascade.

Authors:  Stephanie A Smith; Richard J Travers; James H Morrissey
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-05-28       Impact factor: 8.250

8.  Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.

Authors:  Brian L Henry; Justin Connell; Aiye Liang; Chandravel Krishnasamy; Umesh R Desai
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

9.  In vitro and in vivo characterization of a reversible synthetic heparin analog.

Authors:  Matthew F Whelihan; Brian Cooley; Yongmei Xu; Rafal Pawlinski; Jian Liu; Nigel S Key
Journal:  Thromb Res       Date:  2015-12-10       Impact factor: 3.944

10.  Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity.

Authors:  Jais R Bjelke; Ole H Olsen; Michel Fodje; L Anders Svensson; Susanne Bang; Gert Bolt; Birthe B Kragelund; Egon Persson
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.